155 related articles for article (PubMed ID: 38242072)
1. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose.
Kondratieva A; Palica K; Frøhlich C; Hovd RR; Leiros HS; Erdelyi M; Bayer A
Eur J Med Chem; 2024 Feb; 266():116140. PubMed ID: 38242072
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
[TBL] [Abstract][Full Text] [Related]
3. 1,2,4-Triazole-3-thione analogues with an arylakyl group at position 4 as metallo-β-lactamase inhibitors.
Gavara L; Verdirosa F; Sevaille L; Legru A; Corsica G; Nauton L; Sandra Mercuri P; Sannio F; De Luca F; Hadjadj M; Cerboni G; Vo Hoang Y; Licznar-Fajardo P; Galleni M; Docquier JD; Hernandez JF
Bioorg Med Chem; 2022 Oct; 72():116964. PubMed ID: 36030663
[TBL] [Abstract][Full Text] [Related]
4. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
[TBL] [Abstract][Full Text] [Related]
5. The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli.
Li X; Zhao D; Zhao X; Cheng P; Li F; Sun J; Li Y; Bai J; Zhang X
Eur J Med Chem; 2023 Mar; 250():115225. PubMed ID: 36870273
[TBL] [Abstract][Full Text] [Related]
6. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales.
Ooi N; Lee VE; Chalam-Judge N; Newman R; Wilkinson AJ; Cooper IR; Orr D; Lee S; Savage VJ
J Antimicrob Chemother; 2021 Jan; 76(2):460-466. PubMed ID: 33152764
[TBL] [Abstract][Full Text] [Related]
7. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
[TBL] [Abstract][Full Text] [Related]
8. Aurones and derivatives as promising New Delhi metallo-β-lactamase (NDM-1) inhibitors.
Caburet J; Verdirosa F; Moretti M; Roulier B; Simoncelli G; Haudecoeur R; Ghazi S; Jamet H; Docquier JD; Boucherle B; Peuchmaur M
Bioorg Med Chem; 2024 Jan; 97():117559. PubMed ID: 38109811
[TBL] [Abstract][Full Text] [Related]
9. The Effects of One-Point Mutation on the New Delhi Metallo Beta-Lactamase-1 Resistance toward Carbapenem Antibiotics and β-Lactamase Inhibitors: An In Silico Systematic Approach.
Tran VT; Tran VH; Nguyen DN; Do TG; Vo TP; Nguyen TT; Huynh PNH; Thai KM
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555726
[TBL] [Abstract][Full Text] [Related]
10. 4-(
Gavara L; Verdirosa F; Legru A; Mercuri PS; Nauton L; Sevaille L; Feller G; Berthomieu D; Sannio F; Marcoccia F; Tanfoni S; De Luca F; Gresh N; Galleni M; Docquier JD; Hernandez JF
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32717907
[TBL] [Abstract][Full Text] [Related]
11. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.
Tehrani KHME; Brüchle NC; Wade N; Mashayekhi V; Pesce D; van Haren MJ; Martin NI
ACS Infect Dis; 2020 Jun; 6(6):1366-1371. PubMed ID: 32227874
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
[TBL] [Abstract][Full Text] [Related]
13. Development of Inhibitory Compounds for Metallo-beta-lactamase through Computational Design and Crystallographic Analysis.
Kamo T; Kuroda K; Nimura S; Guo Y; Kondo S; Nukaga M; Hoshino T
Biochemistry; 2024 May; 63(10):1278-1286. PubMed ID: 38690676
[TBL] [Abstract][Full Text] [Related]
14. Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates.
Legru A; Verdirosa F; Vo-Hoang Y; Tassone G; Vascon F; Thomas CA; Sannio F; Corsica G; Benvenuti M; Feller G; Coulon R; Marcoccia F; Devente SR; Bouajila E; Piveteau C; Leroux F; Deprez-Poulain R; Deprez B; Licznar-Fajardo P; Crowder MW; Cendron L; Pozzi C; Mangani S; Docquier JD; Hernandez JF; Gavara L
J Med Chem; 2022 Dec; 65(24):16392-16419. PubMed ID: 36450011
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches.
Muteeb G; Rehman MT; AlAjmi MF; Aatif M; Farhan M; Shafi S
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144666
[TBL] [Abstract][Full Text] [Related]
16. Discovery of hydroxamate as a promising scaffold dually inhibiting metallo- and serine-β-lactamases.
Wu XR; Chen WY; Liu L; Yang KW
Eur J Med Chem; 2024 Feb; 265():116055. PubMed ID: 38134748
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Efficacy of Biocompatible Zinc Ion Chelating Molecules as Metallo-β-Lactamase Inhibitor among NDM Producing
Rudresh SM; Ravi GS; Raksha Y
J Lab Physicians; 2023 Mar; 15(1):62-68. PubMed ID: 37064965
[No Abstract] [Full Text] [Related]
18. Kinetics, Thermodynamics, and Structural Effects of Quinoline-2-Carboxylates, Zinc-Binding Inhibitors of New Delhi Metallo-β-lactamase-1 Re-sensitizing Multidrug-Resistant Bacteria for Carbapenems.
Jia Y; Schroeder B; Pfeifer Y; Fröhlich C; Deng L; Arkona C; Kuropka B; Sticht J; Ataka K; Bergemann S; Wolber G; Nitsche C; Mielke M; Leiros HS; Werner G; Rademann J
J Med Chem; 2023 Sep; 66(17):11761-11791. PubMed ID: 37585683
[TBL] [Abstract][Full Text] [Related]
19. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
[TBL] [Abstract][Full Text] [Related]
20. Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases.
Le Terrier C; Viguier C; Nordmann P; Vila AJ; Poirel L
Antimicrob Agents Chemother; 2024 Feb; 68(2):e0099123. PubMed ID: 38047644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
